Hand Sanitizer (Pharmacies) - BRICS

  • BRICS
  • Revenue in the Hand Sanitizer market is projected to reach US$0.61bn in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.79%, resulting in a market volume of US$0.70bn by 2029.
  • In global comparison, most revenue will be generated in China (US$385.20m in 2024).
  • In relation to total population figures, per person revenues of US$0.19 are generated in 2024.

Key regions: Japan, United States, Europe, United Kingdom, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in BRICS is experiencing significant growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors are all contributing to the expansion of this market.

Customer preferences:
Customers in the BRICS countries have shown a growing preference for hand sanitizers purchased from pharmacies. This is primarily due to the trust and reliability associated with pharmacy products. Customers perceive hand sanitizers bought from pharmacies to be of higher quality and more effective in preventing the spread of germs and diseases. Additionally, pharmacies often offer a wide range of hand sanitizers, allowing customers to choose products that suit their specific needs and preferences.

Trends in the market:
One of the key trends in the Hand Sanitizer (Pharmacies) market in BRICS is the increasing demand for natural and organic hand sanitizers. Customers are becoming more conscious of the ingredients used in personal care products and are opting for products that are free from harmful chemicals. As a result, pharmacies in BRICS countries are expanding their range of natural and organic hand sanitizers to cater to this growing demand. Another trend in the market is the rising popularity of travel-sized hand sanitizers. With an increasing number of people traveling for work or leisure, there is a growing need for portable and convenient hand sanitizers. Pharmacies are capitalizing on this trend by offering a wide variety of travel-sized hand sanitizers, making it easier for customers to maintain good hand hygiene while on the go.

Local special circumstances:
Each BRICS country has its own unique set of circumstances that are influencing the Hand Sanitizer (Pharmacies) market. For example, in Brazil, there has been a surge in demand for hand sanitizers due to the outbreak of mosquito-borne diseases such as dengue and Zika virus. This has led to an increased focus on personal hygiene and a higher demand for hand sanitizers in pharmacies. In Russia, the government has implemented strict regulations on the production and sale of hand sanitizers, which has led to a consolidation of the market. Only licensed pharmacies are allowed to sell hand sanitizers, creating a more controlled and regulated market environment.

Underlying macroeconomic factors:
The Hand Sanitizer (Pharmacies) market in BRICS is also influenced by underlying macroeconomic factors. For instance, the growing middle class in these countries has led to an increase in disposable income, allowing more people to afford hand sanitizers. Additionally, urbanization and increasing awareness of the importance of hand hygiene are driving the demand for hand sanitizers in BRICS countries. In conclusion, the Hand Sanitizer (Pharmacies) market in BRICS is experiencing growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The increasing demand for natural and organic hand sanitizers, the popularity of travel-sized hand sanitizers, and the focus on personal hygiene in the wake of disease outbreaks are all contributing to the expansion of this market. Pharmacies in BRICS countries are adapting to these trends and catering to customer preferences to meet the growing demand for hand sanitizers.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)